Huntington’s disease Archive — Page 1 of 1

The Huntington’s Disease Program is led by new co-directors Amy E. Brown, MD, MS, assistant professor of Neurology, and social worker Spencer Diehl, LCSW. (photo by Erin O. Smith)
April 22, 2025

Clinic supports patients, families affected by Huntington’s disease with multidisciplinary care and empathy

The clinic is part of a collection of subspecialties that work together to treat movement disorders, including Huntington’s disease, multiple system atrophy and progressive supranuclear palsy.

September 7, 2023

Low-flow cerebrospinal fluid in Huntington’s disease: study

Vanderbilt researchers found reduced net flow of cerebrospinal fluid in Huntington’s disease, which could contribute to mutant protein retention and altered responsiveness to medications delivered via the spinal cord.

January 6, 2023

Early effects of Huntington disease

Impairments in brain executive function happen earlier than motor symptoms in people with the gene mutation that causes Huntington disease, suggesting younger ages and cognitive symptoms be considered for any future clinical trials.

silhouette of three men with guns
October 5, 2021

Breaking bad with Huntington’s disease

Illegal activities are a significant clinical problem in individuals with Huntington’s disease, highlighting the need for improved screening measures and protocols to guide patient management.

August 24, 2017

Huntington’s Disease Clinic lands Level 1 designation

The Vanderbilt University Medical Center (VUMC) Huntington’s Disease Clinic is one of only four in the nation to receive a Level 1 Center of Excellence designation.

disabled man plays with his daughter
October 29, 2015

Compound developed at VUMC may delay Huntington’s disease

A compound developed by researchers at Vanderbilt University can improve early symptoms and delay progression of Huntington’s disease in a mouse model of the neurodegenerative disorder.